Frontlight ResearchEarly access
Trial site
Jeollanam
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia3 trials
- Acute lymphoblastic leukaemia2 trials
- Childhood cancers2 trials
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Immune thrombocytopenia (ITP)1 trial
- Lung cancer1 trial
- Myeloproliferative neoplasms1 trial
- Prostate cancer1 trial
- Phase
- Phase 32 trials
- Phase 41 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed2 trials
- Lead sponsor
- Novartis Pharmaceuticals8 trials
Running trials
Recruiting
Recruiting
Recruiting
Long-term Follow up Local Registry Study of Kymriah in South Korea
Recruiting
Active, not recruiting
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Prostate cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026